Vidya Gadang1, Eddy Konaniah1, David Y Hui1, Anja Jaeschke2. 1. From the Department of Pathology, Metabolic Diseases Institute, University of Cincinnati, OH. 2. From the Department of Pathology, Metabolic Diseases Institute, University of Cincinnati, OH. anja.jaeschke@uc.edu.
Abstract
OBJECTIVE: Mitogen-activated protein kinase pathways play an important role in neointima formation secondary to vascular injury, in part by promoting proliferation of vascular smooth muscle cells (VSMC). Mixed-lineage kinase 3 (MLK3) is a mitogen-activated protein kinase kinase kinase that activates multiple mitogen-activated protein kinase pathways and has been implicated in regulating proliferation in several cell types. However, the role of MLK3 in VSMC proliferation and neointima formation is unknown. The aim of this study was to determine the function of MLK3 in the development of neointimal hyperplasia and to elucidate the underlying mechanisms. APPROACH AND RESULTS: Neointima formation was analyzed after endothelial denudation of carotid arteries from wild-type and MLK3-deficient mice. MLK3 deficiency promoted injury-induced neointima formation and increased proliferation of primary VSMC derived from aortas isolated from MLK3-deficient mice compared with wild-type mice. Furthermore, MLK3 deficiency increased the activation of p63Rho guanine nucleotide exchange factor, RhoA, and Rho kinase in VSMC, a pathway known to promote neointimal hyperplasia, and reconstitution of MLK3 expression attenuated Rho kinase activation. Furthermore, cJun NH2-terminal kinase activation was decreased in MLK3-deficient VSMC, and proliferation of wild-type but not MLK3 knockout cells treated with a cJun NH2-terminal kinase inhibitor was attenuated. CONCLUSIONS: We demonstrate that MLK3 limits RhoA activation and injury-induced neointima formation by binding to and inhibiting the activation of p63Rho guanine nucleotide exchange factor, a RhoA activator. In MLK3-deficient cells, activation of p63Rho guanine nucleotide exchange factor proceeds in an unchecked manner, leading to a net increase in RhoA pathway activation. Reconstitution of MLK3 expression restores MLK3/p63Rho guanine nucleotide exchange factor interaction, which is attenuated by feedback from activated cJun NH2-terminal kinase.
OBJECTIVE: Mitogen-activated protein kinase pathways play an important role in neointima formation secondary to vascular injury, in part by promoting proliferation of vascular smooth muscle cells (VSMC). Mixed-lineage kinase 3 (MLK3) is a mitogen-activated protein kinase kinase kinase that activates multiple mitogen-activated protein kinase pathways and has been implicated in regulating proliferation in several cell types. However, the role of MLK3 in VSMC proliferation and neointima formation is unknown. The aim of this study was to determine the function of MLK3 in the development of neointimal hyperplasia and to elucidate the underlying mechanisms. APPROACH AND RESULTS: Neointima formation was analyzed after endothelial denudation of carotid arteries from wild-type and MLK3-deficientmice. MLK3 deficiency promoted injury-induced neointima formation and increased proliferation of primary VSMC derived from aortas isolated from MLK3-deficientmice compared with wild-type mice. Furthermore, MLK3 deficiency increased the activation of p63Rho guanine nucleotide exchange factor, RhoA, and Rho kinase in VSMC, a pathway known to promote neointimal hyperplasia, and reconstitution of MLK3 expression attenuated Rho kinase activation. Furthermore, cJun NH2-terminal kinase activation was decreased in MLK3-deficient VSMC, and proliferation of wild-type but not MLK3 knockout cells treated with a cJun NH2-terminal kinase inhibitor was attenuated. CONCLUSIONS: We demonstrate that MLK3 limits RhoA activation and injury-induced neointima formation by binding to and inhibiting the activation of p63Rho guanine nucleotide exchange factor, a RhoA activator. In MLK3-deficient cells, activation of p63Rho guanine nucleotide exchange factor proceeds in an unchecked manner, leading to a net increase in RhoA pathway activation. Reconstitution of MLK3 expression restores MLK3/p63Rho guanine nucleotide exchange factor interaction, which is attenuated by feedback from activated cJun NH2-terminal kinase.
Authors: F C Tanner; M Boehm; L M Akyürek; H San; Z Y Yang; J Tashiro; G J Nabel; E G Nabel Journal: Circulation Date: 2000-05-02 Impact factor: 29.690
Authors: N Sawada; H Itoh; K Ueyama; J Yamashita; K Doi; T H Chun; M Inoue; K Masatsugu; T Saito; Y Fukunaga; S Sakaguchi; H Arai; N Ohno; M Komeda; K Nakao Journal: Circulation Date: 2000-05-02 Impact factor: 29.690
Authors: Weiguo Zou; Matthew B Greenblatt; Jae-Hyuck Shim; Shashi Kant; Bo Zhai; Sutada Lotinun; Nicholas Brady; Dorothy Zhang Hu; Steven P Gygi; Roland Baron; Roger J Davis; Dallas Jones; Laurie H Glimcher Journal: J Clin Invest Date: 2011-10-03 Impact factor: 14.808
Authors: N Ohashi; A Matsumori; Y Furukawa; K Ono; M Okada; A Iwasaki; T Miyamoto; A Nakano; S Sasayama Journal: Arterioscler Thromb Vasc Biol Date: 2000-12 Impact factor: 8.311
Authors: Vijaya Karoor; Mehdi A Fini; Zoe Loomis; Timothy Sullivan; Louis B Hersh; Evgenia Gerasimovskaya; David Irwin; Edward C Dempsey Journal: Arterioscler Thromb Vasc Biol Date: 2017-11-30 Impact factor: 8.311
Authors: Timothy D Calamaras; Robert A Baumgartner; Mark J Aronovitz; Angela L McLaughlin; Kelly Tam; Daniel A Richards; Craig W Cooper; Nathan Li; Wendy E Baur; Xiaoying Qiao; Guang-Rong Wang; Roger J Davis; Navin K Kapur; Richard H Karas; Robert M Blanton Journal: Am J Physiol Heart Circ Physiol Date: 2018-10-26 Impact factor: 4.733
Authors: Scott D Collum; Ning-Yuan Chen; Adriana M Hernandez; Ankit Hanmandlu; Heather Sweeney; Tinne C J Mertens; Tingting Weng; Fayong Luo; Jose G Molina; Jonathan Davies; Ian P Horan; Nick W Morrell; Javier Amione-Guerra; Odeaa Al-Jabbari; Keith Youker; Wenchao Sun; Jayakumar Rajadas; Paul L Bollyky; Bindu H Akkanti; Soma Jyothula; Neeraj Sinha; Ashrith Guha; Harry Karmouty-Quintana Journal: Br J Pharmacol Date: 2017-08-17 Impact factor: 8.739
Authors: Timothy D Calamaras; Suchita Pande; Robert Au Baumgartner; Seung Kyum Kim; Joseph C McCarthy; Gregory L Martin; Kelly Tam; Angela L McLaughlin; Guang-Rong Wang; Mark J Aronovitz; Weiyu Lin; Jonathan I Aguirre; Paulina Baca; Peiwen Liu; Daniel A Richards; Roger J Davis; Richard H Karas; Iris Z Jaffe; Robert M Blanton Journal: JCI Insight Date: 2021-09-22